Corticosteroid Treatment in Chronic Rhinosinusitis: The Possibilities and the Limits

Immunology and Allergy Clinics of North America

Volumn 29, Issue 4, 2009, Pages 657-668

  Mullol, Joaquim ^a,b   Obando, Andrés ^a   Pujols, Laura ^b   Alobid, Isam ^a  

^a Clínica de l'Olfacte   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Chronic rhinosinusitis; Corticosteroids; Efficay and safety; Endoscopic sinus surgery; Nasal polyps

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CICLESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MOMETASONE FUROATE; PREDNISONE; STEROID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BONE DENSITY; BONE GROWTH; CATARACT; CHILD HEALTH CARE; CHRONIC RHINOSINUSITIS; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG DISPOSITION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SAFETY; ENDOSCOPIC SURGERY; EPISTAXIS; EVIDENCE BASED MEDICINE; GLAUCOMA; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATORY INFILTRATE; NOSE POLYP; OSTEOPOROSIS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT INFLAMMATION; REVIEW; RHINOSINUSITIS; SIDE EFFECT; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; CHILD; CHRONIC DISEASE; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; NASAL POLYPS; PREGNANCY; PREGNANCY COMPLICATIONS; RHINITIS; SINUSITIS;

EID: 70350379573     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.07.001     Document Type: Review

References (73)

1. Benninger M.S., Ferguson B.J., Hadley J.A., et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129 Suppl 3 (2003) S1-32
2. Meltzer E.O., Hamilos D.L., Hadley J.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114 suppl 6 (2004) S155-S212
3. 3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 20 (2007) 1-136
4. GINA 2006 Workshop Report: Global strategy for asthma management and prevention. WHO/NHLBI workshop report: National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659.
5. 2LEN). Allergy 61 9 (2006) 1086-1096
6. Bousquet J., Khaltaev N., Cruz A.A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 63 suppl 86 (2008) 8-160
7. Pujols L., Mullol J., Torrego A., et al. Glucocorticoid receptors in human airways. Allergy 59 10 (2004) 1042-1052
8. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353 16 (2005) 1711-1723
9. Ray A., Siegel M.D., Prefontine K.E., et al. Anti-inflammation: direct physical association and functional antagonism between transcription factor NF-KB and the glucocorticoid receptor. Chest 107 suppl 3 (1995) 139S
10. König H., Ponta H., Rahmsdorf H.J., et al. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP/1 activity without altering AP-1 site occupation in vivo. EMBO J 11 6 (1992) 2241-2246
11. Barnes P.J., and Adcock I.M. Glucocorticoid resistance in inflammatory diseases. Lancet 373 9678 (2009) 1905-1917
12. Pujols L., Mullol J., Roca-Ferrer J., et al. Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol 283 4 (2002) C1324-C1331
13. Pujols L., Mullol J., and Picado C. Alpha and beta glucocorticoid receptors: relevance in airway diseases. Curr Allergy Asthma Rep 7 2 (2007) 93-99
14. Pujols L, J Mullol, C Picado. Importance of glucocorticoid receptors in upper and lower airways. Front Biosci, in press.
15. Pujols L., Mullol J., Benitez P., et al. Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. Respir Med 97 1 (2003) 90-96
16. Pujols L., Mullol J., Pérez M., et al. Expression of the human glucocorticoid receptor a and b isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol 24 1 (2001) 49-57
17. Pujols L., Alobid I., Benítez P., et al. Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. Allergy 63 10 (2008) 1377-1386
18. Valotis A., and Högge P. Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate. Respir Res 8 1 (2007) 54
19. Derendorf H., and Meltzer E.O. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 63 10 (2008) 1292-1300
20. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare?. J Allergy Clin Immunol 104 4 (1999) S144-S149
21. Lipworth B.J., and Seckl J.R. Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 52 5 (1997) 476-482
22. Szefler S.J. Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 108 Suppl 1 (2001) S26-S31
23. Lund V.J., Flood J., Sykes A.P., et al. Effect of fluticasonein severe polyposis. Arch Otolaryngol Head Neck Surg 124 5 (1998) 513-518
24. Vendelo Johansen L., Illum P., Kristensen S., et al. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 18 6 (1993) 524-527
25. Holmberg K., Juliusson S., Balder B., et al. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 78 3 (1997) 270-276
26. Small C.B., Hernandez J., Reyes A., et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 116 6 (2005) 1275-1281
27. Benitez P., Alobid I., De Haro J., et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 116 5 (2006) 770-775
28. Mygind N., Pedersen C.B., Prytz S., et al. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 5 2 (1975) 159-164
29. Deuschl H., and Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 15 1 (1977) 17-23
30. Lildholdt T., Rundcrantz H., and Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 20 1 (1995) 26-30
31. Stjarne P., Blomgren K., Caye-Thomasen P., et al. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo controlled study. Acta Otolaryngol 126 6 (2006) 606-612
32. Alobid I., Benítez P., Bernal-Sprekelsen M., et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 60 4 (2005) 452-458
33. Aukema A.A., Mulder P.G., and Fokkens W.J. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol 115 5 (2005) 1017-1023
34. Radenne F., Lamblin C., Vandezande L.M., et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 104 1 (1999) 79-84
35. Rowe-Jones J.M., Medcalf M., Durham S.R., et al. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 43 1 (2005) 2-10
36. Dingsor G., Kramer J., Olsholt R., et al. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double blind, parallel, placebo controlled study. Rhinology 23 1 (1985) 49-58
37. Cuenant G., Stipon J.P., Plante-Longchamp G., et al. Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec 48 4 (1986) 226-232
38. Sykes D.A., Wilson R., Chan K.L., et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet 2 8503 (1986) 359-360
39. Parikh A., Scadding G.K., Darby Y., et al. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 39 2 (2001) 75-79
40. Lavigne F., Cameron L., Renzi P.M., et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 112 5 (2002) 858-864
41. Lund V.J., Black J.H., Szabó L.Z., et al. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 42 2 (2004) 57-62
42. Cave A., Arlett P., and Lee E. Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects. Pharmacol Ther 83 3 (1999) 153-179
43. Holm A.F., Fokkens W.J., Godthelp T., et al. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol 23 1 (1998) 69-73
44. Ernst P., Baltzan M., Deschênes J., et al. Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 27 6 (2006) 1168-1174
45. Licata A.A. Systemic effects of fluticasone nasal spray: report of 2 cases. Endocr Pract 11 3 (2005) 194-196
46. Mehle M.E. Are nasal steroids safe?. Curr Opin Otolaryngol Head Neck Surg 11 3 (2003) 201-205
47. Schenkel E.J., Skoner D.P., Bronsky E.A., et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 105 2 (2000) E22
48. Skoner D. Update of growth effects of inhaled and intranasal corticosteroids. Curr Opin Allergy Clin Immunol 2 1 (2002) 7-10
49. Salib R.J., and Howarth P.H. Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 26 12 (2003) 863-893
50. Van Camp C., and Clement P.A. Results of oral steroid treatment in nasal polyposis. Rhinology 32 1 (1994) 5-9
51. Hissaria P., Smith W., Wormald P.J., et al. Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Allergy Clin Immunol 118 1 (2006) 128-133
52. Walsh L.J., Lewis S.A., Wong C.A., et al. The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 166 5 (2002) 691-695
53. Becker S.S., Rasamny J.K., Han J.K., et al. Steroid injection for sinonasal polyps: the University of Virginia experience. Am J Rhinol 21 1 (2007) 64-69
54. McGrew R.N., Wilson R.S., and Havener W.H. Sudden blindness secondary to injections of common drugs in the head and neck: I. Clinical experiences. Otolaryngology 86 1 (1978) 147-151
55. Scadding G.K. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 108 suppl 1 (2001) S59-S64
56. Fokkens W.J., and Scadding G.K. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. Pediatr Allergy Immunol 15 3 (2004) 261-266
57. Baena-Cagnani C.E. Safety and tolerability of treatments for allergic rhinitis in children. Drug Saf 27 12 (2004) 883-898
58. Al Sayyad J.J., Fedorowicz Z., Alhashimi D., et al. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database Syst Rev 24 1 (2007) CD003163
59. Pedersen S. Assessing the effect of intranasal steroids on growth. J Allergy Clin Immunol 108 suppl 1 (2001) S40-S44
60. Skoner D.P., Gentile D., Angelini B., et al. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol 90 1 (2003) 56-62
61. Agertoft L., and Pedersen S. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. J Allergy Clin Immunol 104 5 (1999) 948-952
62. Allen D.B., Meltzer E.O., Lemanske Jr. R.F., et al. No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 23 6 (2002) 407-413
63. Möller C., Ahlström H., Henricson K.A., et al. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clin Exp Allergy 33 6 (2003) 816-822
64. Skoner D.P., Maspero J., Banerji D., et al. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 121 1 (2008) e1-14
65. Skoner D.P., Rachelefsky G.S., Meltzer E.O., et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 105 2 (2000) E23
66. Kallen B., Rydhstroem H., and Aberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 93 3 (1999) 392-395
67. Schatz M., Zeiger R.S., Harden K., et al. The safety of asthma and allergic medications during pregnancy. J Allergy Clin Immunol 100 3 (1997) 301-306
68. Ellegard E.K., Hellgren M., and Karlsson N.G. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 26 5 (2001) 394-400
69. Rodriguez-Pinilla E., and Martinez-Frias M.L. Corticosteroids during pregnancy and oral clefts. A case control study. Teratology 58 1 (1998) 2-5
70. Einarson A., Bailey B., Jung S., et al. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 78 2 (1997) 183-186
71. Lehrer S., Sotne J., Lapinski R., et al. Association between pregnancy-induced hypertension and asthma during pregnancy. Am J Obstet Gynecol 168 5 (1993) 1463-1466
72. Meltzer E., Hamilos D., Hadley J., et al. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol 118 Suppl 5 (2006) S17-S61
73. Joe S., Thambi R., and Huang J. A systematic review of the use of intranasal steroids in the treatment of chronic rhinosinusitis. Otolaryngol Head Neck Surg 139 3 (2008) 340-347